Medicina, Vol. 55 No. 4, 2019.
Pregledni rad
https://doi.org/10.21860/medflum2019_227123
Update on treatment of gestational diabetes
Nika Hlača
orcid.org/0000-0002-0517-5462
; Klinički bolnički centar Rijeka, Rijeka, Hrvatska
Sanja Klobučar Majanović
orcid.org/0000-0002-0287-4735
; Zavod za endokrinologiju, dijabetes i bolesti metabolizma, Klinika za internu medicinu, Klinički bolnički centar Rijeka i Medicinski fakultet Sveučilišta u Rijeci, Rijeka, Hrvatska
Sažetak
Gestational diabetes (GDM) is the most common metabolic disorder in pregnant women associated with adverse pregnancy outcomes and long-term maternal and offspring health risks. Worldwide GDM prevalence is increasing in the setting of the obesity epidemic, advanced maternal age, and tighter diagnostic criteria. Lifestyle interventions that promote healthy eating behaviours and healthy weight gain play a key role in the management of GDM. If glycemic targets are not achieved with diet alone, insulin therapy is recommended since oral antihyperglycemic agents lack long-term safety data. Because GDM is associated with an increased lifetime maternal risk for type 2 diabetes women should be followed up regularly and screened for diabetes 4- to 12-weeks postpartum and every 1–3 years thereafter. The aim of this article is to present an update on treatment of gestational diabetes.
Ključne riječi
dietary intervention; gestational diabetes; insulin; metformin
Hrčak ID:
227123
URI
Datum izdavanja:
1.12.2019.
Posjeta: 2.996 *